Marketdash

Rocket Lab's Stock Gets a Lift From a Record Deal and a Steady Launch Cadence

MarketDash
Rocket Lab shares are moving higher, buoyed by a massive new hypersonic contract and another successful satellite launch, while technical indicators paint a mixed but intriguing picture.

Get Market Alerts

Weekly insights + SMS alerts

Shares of Rocket Lab Corp. (RKLB) were ticking higher on Monday, catching a ride on a broader market updraft as the Nasdaq climbed. But the company gave investors more than just a market tailwind to think about, with news of a landmark contract and another flawless launch.

Another Week, Another Successful Launch

Last week, Rocket Lab fired up its Electron rocket for the 84th time. The mission, dubbed "Eight Days A Week," successfully placed the eighth StriX satellite for Japan's Synspective into a precise orbit about 573 kilometers above Earth. It's the company's eighth launch for Synspective, maintaining a perfect 100% success rate for the customer's satellites. The partnership has gotten so comfortable that they've extended it: the deal now includes 19 more launches through 2028, bringing the total planned missions to 27.

A Supersonic-Sized Deal

While launching satellites is the core business, Rocket Lab is also making serious inroads in a faster, more secretive market: hypersonics. The company recently locked down a $190 million contract—its largest ever—to provide 20 launches using its HASTE (Hypersonic Accelerator Suborbital Test Electron) vehicle. The work is part of the MACH-TB 2.0 program, which is led by defense contractor Kratos Defense & Security Solutions Inc. (KTOS).

This four-year deal is a big deal. It pushes Rocket Lab's total backlog of future work above the $2 billion mark and solidifies its growing role in national security and cutting-edge hypersonic test missions.

Get Market Alerts

Weekly insights + SMS (optional)

What the Charts Are Saying

The stock's move higher came on a good day for the market, with major indices like the S&P 500 and the Russell 2000 posting solid gains. But if you look under the hood at Rocket Lab's own technical indicators, the picture is a bit more nuanced.

The stock is currently trading below its 20-day and 50-day simple moving averages (SMAs), which suggests some near-term softness. However, it's sitting above its 100-day and 200-day SMAs, pointing to longer-term strength. That longer-term trend is hard to ignore: over the past year, the shares are up a staggering 235.43% and are trading much closer to their 52-week high than their low.

The Relative Strength Index (RSI) is sitting at 44.47, which is smack in the middle of neutral territory—the stock isn't overbought or oversold. Meanwhile, the MACD indicator is showing a bullish signal, as the MACD line is above its signal line. Put together, these signals suggest mixed momentum. For traders, the playbook might be to watch for a breakout if the stock can push past key resistance levels.

  • Key Resistance: $75.00
  • Key Support: $64.00

The Financial Forecast and What the Pros Think

Rocket Lab is expected to report its next set of financial results on May 7, 2026. The estimates are looking for progress: an expected loss of 8 cents per share, which is an improvement from a loss of 12 cents, and revenue of $191.01 million, up significantly from $122.57 million. One number that jumps out is the valuation, with a forward price-to-earnings (P/E) ratio of 386.2x, reflecting high growth expectations.

Analysts, on the whole, are still fans. The stock carries a consensus Buy rating with an average price target of $68.29. Recent analyst actions have been supportive:

  • Clear Street: Initiated coverage with a Buy rating and an $88.00 price target (March 19).
  • Cantor Fitzgerald: Maintained an Overweight rating and an $85.00 price target (March 13).
  • Needham: Maintained a Buy rating but lowered its price target to $95.00 (February 27).

ETF Exposure: A Built-In Buyer (or Seller)

Rocket Lab isn't just a stock you buy directly; it's also a significant holding in several popular exchange-traded funds (ETFs). This creates a kind of automatic trading mechanism. Because of its weight in these funds, significant money flowing into or out of the ETFs can force fund managers to buy or sell Rocket Lab shares to match their indexes.

Some of the key ETFs with major exposure include:

  • SPDR S&P Aerospace & Defense ETF (XAR): 5.66% Weight
  • ARK Autonomous Technology & Robotics ETF (ARKQ): 4.97% Weight
  • ARK Space & Defense Innovation ETF (ARKX): 7.81% Weight

At the time of reporting, Rocket Lab shares were up 0.96%, trading at $67.87.

Rocket Lab's Stock Gets a Lift From a Record Deal and a Steady Launch Cadence

MarketDash
Rocket Lab shares are moving higher, buoyed by a massive new hypersonic contract and another successful satellite launch, while technical indicators paint a mixed but intriguing picture.

Get Market Alerts

Weekly insights + SMS alerts

Shares of Rocket Lab Corp. (RKLB) were ticking higher on Monday, catching a ride on a broader market updraft as the Nasdaq climbed. But the company gave investors more than just a market tailwind to think about, with news of a landmark contract and another flawless launch.

Another Week, Another Successful Launch

Last week, Rocket Lab fired up its Electron rocket for the 84th time. The mission, dubbed "Eight Days A Week," successfully placed the eighth StriX satellite for Japan's Synspective into a precise orbit about 573 kilometers above Earth. It's the company's eighth launch for Synspective, maintaining a perfect 100% success rate for the customer's satellites. The partnership has gotten so comfortable that they've extended it: the deal now includes 19 more launches through 2028, bringing the total planned missions to 27.

A Supersonic-Sized Deal

While launching satellites is the core business, Rocket Lab is also making serious inroads in a faster, more secretive market: hypersonics. The company recently locked down a $190 million contract—its largest ever—to provide 20 launches using its HASTE (Hypersonic Accelerator Suborbital Test Electron) vehicle. The work is part of the MACH-TB 2.0 program, which is led by defense contractor Kratos Defense & Security Solutions Inc. (KTOS).

This four-year deal is a big deal. It pushes Rocket Lab's total backlog of future work above the $2 billion mark and solidifies its growing role in national security and cutting-edge hypersonic test missions.

Get Market Alerts

Weekly insights + SMS (optional)

What the Charts Are Saying

The stock's move higher came on a good day for the market, with major indices like the S&P 500 and the Russell 2000 posting solid gains. But if you look under the hood at Rocket Lab's own technical indicators, the picture is a bit more nuanced.

The stock is currently trading below its 20-day and 50-day simple moving averages (SMAs), which suggests some near-term softness. However, it's sitting above its 100-day and 200-day SMAs, pointing to longer-term strength. That longer-term trend is hard to ignore: over the past year, the shares are up a staggering 235.43% and are trading much closer to their 52-week high than their low.

The Relative Strength Index (RSI) is sitting at 44.47, which is smack in the middle of neutral territory—the stock isn't overbought or oversold. Meanwhile, the MACD indicator is showing a bullish signal, as the MACD line is above its signal line. Put together, these signals suggest mixed momentum. For traders, the playbook might be to watch for a breakout if the stock can push past key resistance levels.

  • Key Resistance: $75.00
  • Key Support: $64.00

The Financial Forecast and What the Pros Think

Rocket Lab is expected to report its next set of financial results on May 7, 2026. The estimates are looking for progress: an expected loss of 8 cents per share, which is an improvement from a loss of 12 cents, and revenue of $191.01 million, up significantly from $122.57 million. One number that jumps out is the valuation, with a forward price-to-earnings (P/E) ratio of 386.2x, reflecting high growth expectations.

Analysts, on the whole, are still fans. The stock carries a consensus Buy rating with an average price target of $68.29. Recent analyst actions have been supportive:

  • Clear Street: Initiated coverage with a Buy rating and an $88.00 price target (March 19).
  • Cantor Fitzgerald: Maintained an Overweight rating and an $85.00 price target (March 13).
  • Needham: Maintained a Buy rating but lowered its price target to $95.00 (February 27).

ETF Exposure: A Built-In Buyer (or Seller)

Rocket Lab isn't just a stock you buy directly; it's also a significant holding in several popular exchange-traded funds (ETFs). This creates a kind of automatic trading mechanism. Because of its weight in these funds, significant money flowing into or out of the ETFs can force fund managers to buy or sell Rocket Lab shares to match their indexes.

Some of the key ETFs with major exposure include:

  • SPDR S&P Aerospace & Defense ETF (XAR): 5.66% Weight
  • ARK Autonomous Technology & Robotics ETF (ARKQ): 4.97% Weight
  • ARK Space & Defense Innovation ETF (ARKX): 7.81% Weight

At the time of reporting, Rocket Lab shares were up 0.96%, trading at $67.87.